KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Interest Expenses: 2011-2021

Historic Interest Expenses for TherapeuticsMD (TXMD) over the last 8 years, with Dec 2021 value amounting to $32.9 million.

  • TherapeuticsMD's Interest Expenses changed negligibly% to $3,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $10,000, marking a year-over-year decrease of 91.53%. This contributed to the annual value of $32.9 million for FY2021, which is 15.17% up from last year.
  • TherapeuticsMD's Interest Expenses amounted to $32.9 million in FY2021, which was up 15.17% from $28.6 million recorded in FY2020.
  • TherapeuticsMD's Interest Expenses' 5-year high stood at $32.9 million during FY2021, with a 5-year trough of $4.7 million in FY2018.
  • Its 3-year average for Interest Expenses is $26.3 million, with a median of $28.6 million in 2020.
  • Data for TherapeuticsMD's Interest Expenses shows a peak YoY soared of 271.58% (in 2019) over the last 5 years.
  • TherapeuticsMD's Interest Expenses (Yearly) stood at $4.7 million in 2018, then surged by 271.58% to $17.4 million in 2019, then spiked by 64.43% to $28.6 million in 2020, then rose by 15.17% to $32.9 million in 2021.